Stock BSPM BIOSTAR PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Biostar Pharmaceuticals, Inc.

Equities

BSPM

US0906783016

Market Closed - OTC Markets
Other stock markets
 02:52:33 2024-05-30 pm EDT 		5-day change 1st Jan Change
0.000014 USD -86.00% Intraday chart for Biostar Pharmaceuticals, Inc. -.--% -86.00%
2023 Biostar Pharmaceuticals, Inc. Announces FDA Approval of Utidelone Injectable Phase 2/3 Multi-National Clinical Trial for Non-Small Cell Lung Cancer CI
2023 Biostar Pharma, Inc. Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BIOSTAR PHARMACEUTICALS, INC. Stock Biostar Pharmaceuticals, Inc.
 36 - - - - -
NOVO NORDISK A/S Stock Novo Nordisk A/S
 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
 350B - - - -
MERCK & CO., INC. Stock Merck & Co., Inc.
 328B
ABBVIE INC. Stock AbbVie Inc.
 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
 246B
  1. Stock Market
  2. Equities
  3. BSPM Stock
  4. Charts Biostar Pharmaceuticals, Inc.
  5. Sector Chart